1 Min Read
Feb 13 (Reuters) - Zogenix Inc :
* Zogenix announces initiation of clinical efficacy portion of study 1504 for ZX008 in dravet syndrome Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.